CLIMB BIO INC. - COMMON STOCK

Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement

27 июн 2024 16:01:00 Источник Nasdaq GlobeNewswire

Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement

11 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire

Eliem Therapeutics Announces Plans to Explore Strategic Alternatives

20 июл 2023 06:45:00 Источник Nasdaq GlobeNewswire

Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights

11 май 2023 16:10:00 Источник Nasdaq GlobeNewswire

Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlights

06 мар 2023 16:10:00 Источник Nasdaq GlobeNewswire

Eliem Therapeutics Provides Strategic Update and Announces Leadership Transition

09 фев 2023 16:01:00 Источник Nasdaq GlobeNewswire

Eliem Therapeutics at the 5th Annual Evercore ISI HealthCONx Virtual Conference

30 ноя 2022 07:00:00 Источник Nasdaq GlobeNewswire

Eliem Therapeutics Reports Third Quarter Financial and Business Highlights

14 ноя 2022 06:10:00 Источник Nasdaq GlobeNewswire

Eliem Therapeutics to Participate at Two Upcoming Investor Conferences

08 ноя 2022 07:00:02 Источник Nasdaq GlobeNewswire

Eliem Therapeutics Provides Update on Pipeline Progress

05 окт 2022 07:00:00 Источник Nasdaq GlobeNewswire

Eliem Therapeutics Reports Second Quarter Financial and Business Highlights

15 авг 2022 06:10:00 Источник Nasdaq GlobeNewswire

Eliem Therapeutics Provides ETX-810 Program Update

02 авг 2022 07:00:01 Источник Nasdaq GlobeNewswire

Eliem Announces Updated Development Plans and the Advancement of ETX-155 for the Treatment of Major Depressive Disorder

18 июл 2022 07:00:00 Источник Nasdaq GlobeNewswire

Eliem Therapeutics to Host Virtual Investor Event on July 21, 2022

07 июл 2022 07:00:00 Источник Nasdaq GlobeNewswire

Eliem Therapeutics Announces Last Patient Completed Dosing in Phase 2a Study of ETX-810 in Patients with Lumbosacral Radicular Pain (LSRP)

27 июн 2022 16:01:00 Источник Nasdaq GlobeNewswire

Eliem Therapeutics Reports First Quarter Financial and Business Highlights

16 май 2022 06:10:00 Источник Nasdaq GlobeNewswire

Eliem Provides Update on ETX-810 and ETX-155 Clinical Programs

25 апр 2022 07:00:00 Источник Nasdaq GlobeNewswire

Eliem Therapeutics Appoints Susan Franks as Senior Vice President and Head of Regulatory Affairs

05 апр 2022 07:00:01 Источник Nasdaq GlobeNewswire

Eliem Therapeutics to Present at Stifel’s 2022 CNS Days

21 мар 2022 07:00:00 Источник Nasdaq GlobeNewswire

Eliem Therapeutics Reports Fourth Quarter and Year-End Financial and Business Highlights

07 мар 2022 16:10:00 Источник Nasdaq GlobeNewswire